|
Market Cap (23-May) $4,114,900 (1,059th) |
Close (30-Jun) $0.010 |
Volume (30-Jun) 1,641,703 |
Shortsold (24-Jan) 39,007 (0.00%) (630th) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
PAB released this announcement to the ASX on 27 July 2022, 11:58. The announcement is not marked as price sensitive, and is 19 page(s) in length and 357.05kb in size.
You can view all announcements from PAB and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAB was 0.031% short sold according to ASIC data. It was ranked the 580th most shorted stock on the ASX. It remains ranked 630th as of the latest reported data (24 January 2025).
| Other Recent Announcements from PAB | |
|---|---|
| PAT-DX1 GLP toxicology reports received | 24 May 2023, 9:12 |
| Notification regarding unquoted securities - PAB | 11 May 2023, 14:04 |
| Appendix 4C - Quarterly - 31 March 2023 | 24 April 2023, 10:10 |
| Change in substantial holding | 27 July 2022, 11:58 |
| PAT-DX1 Engineering Run Successfully Completed | 4 July 2022, 9:08 |
| New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis | 14 June 2022, 8:53 |
| CBCF funding to support deoxymab brain cancer development | 3 June 2022, 14:07 |
You must be logged in to post a reply.
Patrys 